Search hospitals > Michigan > Ann Arbor
Saint Joseph Mercy Hospital
Claim this profileAnn Arbor, Michigan 48105
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Ovarian Cancer
Conducts research for Cancer
Conducts research for Breast cancer
492 reported clinical trials
10 medical researchers
Summary
Saint Joseph Mercy Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Cancer, Breast cancer and other specialties. Saint Joseph Mercy Hospital is involved with conducting 492 clinical trials across 553 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.Area of expertise
1Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
Stage IV
Top PIs
Tareq Al BaghdadiGenesys Hurley Cancer Institute8 years of reported clinical research
Expert in Cancer
Expert in Pancreatic Cancer
73 reported clinical trials
130 drugs studied
Christopher M. Reynolds, MDSaint Joseph Mercy Hospital2 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
51 reported clinical trials
104 drugs studied
Philip J. StellaSaint Joseph Mercy Hospital5 years of reported clinical research
Expert in Lung Cancer
Expert in Non-Small Cell Lung Cancer
38 reported clinical trials
89 drugs studied
Elie G. DibGenesys Hurley Cancer Institute6 years of reported clinical research
Studies Multiple Myeloma
Studies Breast Cancer
38 reported clinical trials
105 drugs studied
Clinical Trials running at Saint Joseph Mercy Hospital
Lung Cancer
Cancer
Bladder Cancer
Breast Cancer
Breast cancer
Ovarian Cancer
Prostate Cancer
Esophageal cancer
Multiple Myeloma
Kidney Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
High-Dose Radiation + Chemotherapy and Immunotherapy
for Non-Small Cell Lung Cancer
This trial tests whether adding a precise form of radiation therapy to the usual treatment improves outcomes for patients with advanced lung cancer that can't be operated on. The goal is to see if this combination helps patients live longer and prevents cancer from worsening. This form of radiation therapy has shown promise in improving survival rates in patients with various stages of lung cancer.
Recruiting2 awards Phase 314 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Saint Joseph Mercy Hospital?
Saint Joseph Mercy Hospital is a medical facility located in Ann Arbor, Michigan. This center is recognized for care of Lung Cancer, Breast Cancer, Ovarian Cancer, Cancer, Breast cancer and other specialties. Saint Joseph Mercy Hospital is involved with conducting 492 clinical trials across 553 conditions. There are 10 research doctors associated with this hospital, such as Tareq Al Baghdadi, Christopher M. Reynolds, MD, Philip J. Stella, and Elie G. Dib.
Where is Saint Joseph Mercy Hospital located?
To reach St. Joseph Mercy Hospital in Ann Arbor, Michigan, take I-94 to exit 180B and head north on Washtenaw Avenue. Turn right onto Huron Parkway, then left onto East Huron River Drive. The hospital is located at 5301 East Huron River Drive, Ann Arbor, MI 48106.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Saint Joseph Mercy Hospital, please reach out to the Patient Accounts department at (877) 727-9190. They offer support with medical bills, payment options, financial assistance applications, and insurance benefits. Detailed information on the hospital's financial assistance policy is available on their website.
What insurance does Saint Joseph Mercy Hospital accept?
Saint Joseph Mercy Hospital accepts a variety of health insurance types, including commercial, Medicare, and Medicaid, from many local and national carriers. Before scheduling visits, confirm coverage and restrictions with your insurance provider, as some services may need to be scheduled at specific network locations to avoid denial of coverage. For specific insurance plans accepted and coverage questions, contact your insurance company directly or call the member services number on your insurance card.
What awards or recognition has Saint Joseph Mercy Hospital received?
Saint Joseph Mercy Hospital in Ann Arbor, Michigan, was recognized as the No. 1 teaching hospital in the U.S. by Fortune/IBM Watson Health in 2020. It has been named one of the nation's 100 Top Hospitals by IBM Watson Health ten times, including in 2019. The hospital's health system received a $19.3 million grant in 2019 to lead the Michigan Cancer Research Consortium, one of the largest federal grants Trinity Health has ever received.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.